Both in Surgical Instruments
Intelligent Bio Solutions vs Sonoma Pharmaceuticals
Over the past year INBS returned −85.7% and SNOA returned −68.4%; their daily moves had a correlation of 0.09.
INBS −85.7% SNOA −68.4%Growth of $1, one year, split-adjusted
| Metric | INBS | SNOA |
|---|---|---|
| Price | $1.63 | $1.25 |
| Market cap | $5.4M | $6.0M |
| Today | −1.21% | −1.19% |
| 1 month | −30.9% | −5.0% |
| 6 months | −43.2% | −39.9% |
| Year to date | −82.9% | −65.8% |
| 1 year | −85.4% | −69.2% |
| Revenue growth (YoY) | +35.8% | +59.6% |
| Gross margin | 46.8% | 40.2% |
| Net margin | −341.0% | −5.2% |
| P/E (TTM) | — | — |
| Price / sales | 1.3× | 0.3× |
| Net cash | $4.0M | $5.2M |
| Dividend yield | — | — |
| Volatility (60d) | 102.3% | 56.3% |
| Short % of float | 5.1% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).